151 related articles for article (PubMed ID: 15714588)
1. Much anticipated--the bioactive conformation of epothilone and its binding to tubulin.
Heinz DW; Schubert WD; Höfle G
Angew Chem Int Ed Engl; 2005 Feb; 44(9):1298-301. PubMed ID: 15714588
[No Abstract] [Full Text] [Related]
2. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
[TBL] [Abstract][Full Text] [Related]
3. Comparative binding energy (COMBINE) analysis supports a proposal for the binding mode of epothilones to β-tubulin.
Coderch C; Klett J; Morreale A; Fernando Díaz J; Gago F
ChemMedChem; 2012 May; 7(5):836-43. PubMed ID: 22431398
[TBL] [Abstract][Full Text] [Related]
4. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide.
Sánchez-Pedregal VM; Kubicek K; Meiler J; Lyothier I; Paterson I; Carlomagno T
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7388-94. PubMed ID: 17036370
[No Abstract] [Full Text] [Related]
5. Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK.
Nagano S; Li H; Shimizu H; Nishida C; Ogura H; Ortiz de Montellano PR; Poulos TL
J Biol Chem; 2003 Nov; 278(45):44886-93. PubMed ID: 12933799
[TBL] [Abstract][Full Text] [Related]
6. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
[TBL] [Abstract][Full Text] [Related]
7. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
Shi G; Wang Y; Jin Y; Chi S; Shi Q; Ge M; Wang S; Zhang X; Xu S
J Biomol Struct Dyn; 2012; 30(5):559-73. PubMed ID: 22731768
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition of epothilones by microtubules and tubulin dimers revealed by biochemical and NMR approaches.
Canales A; Nieto L; Rodríguez-Salarichs J; Sánchez-Murcia PA; Coderch C; Cortés-Cabrera A; Paterson I; Carlomagno T; Gago F; Andreu JM; Altmann KH; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2014 Apr; 9(4):1033-43. PubMed ID: 24524625
[TBL] [Abstract][Full Text] [Related]
9. Computational study of binding of epothilone A to β-tubulin.
Kamel K; Kolinski A
Acta Biochim Pol; 2011; 58(2):255-60. PubMed ID: 21633729
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for drug resistance conferred by β-tubulin mutations: a molecular modeling study on native and mutated tubulin complexes with epothilone B.
Navarrete KR; Alderete JB; Jiménez VA
J Biomol Struct Dyn; 2015; 33(12):2530-40. PubMed ID: 26081685
[TBL] [Abstract][Full Text] [Related]
11. Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity.
Buey RM; Díaz JF; Andreu JM; O'Brate A; Giannakakou P; Nicolaou KC; Sasmal PK; Ritzén A; Namoto K
Chem Biol; 2004 Feb; 11(2):225-36. PubMed ID: 15123284
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of novel epothilone analogues by means of a common pharmacophore and a QSAR pseudoreceptor model for taxanes and epothilones.
Forli S; Manetti F; Altmann KH; Botta M
ChemMedChem; 2010 Jan; 5(1):35-40. PubMed ID: 19904799
[No Abstract] [Full Text] [Related]
13. Quantum-chemical study on the bioactive conformation of epothilones.
Jiménez VA
J Chem Inf Model; 2010 Dec; 50(12):2176-90. PubMed ID: 21077585
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling study on the tubulin-binding modes of epothilone derivatives: Insight into the structural basis for epothilones activity.
Jiménez VA; Alderete JB; Navarrete KR
Chem Biol Drug Des; 2017 Dec; 90(6):1247-1259. PubMed ID: 28632973
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of the activity of the microtubule-stabilizing agent epothilone a studied by NMR spectroscopy in solution.
Reese M; Sánchez-Pedregal VM; Kubicek K; Meiler J; Blommers MJ; Griesinger C; Carlomagno T
Angew Chem Int Ed Engl; 2007; 46(11):1864-8. PubMed ID: 17274084
[No Abstract] [Full Text] [Related]
16. The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents.
Carlomagno T; Blommers MJ; Meiler J; Jahnke W; Schupp T; Petersen F; Schinzer D; Altmann KH; Griesinger C
Angew Chem Int Ed Engl; 2003 Jun; 42(22):2511-5. PubMed ID: 12800173
[No Abstract] [Full Text] [Related]
17. The binding mode of side chain- and C3-modified epothilones to tubulin.
Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T
ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490
[TBL] [Abstract][Full Text] [Related]
18. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
[TBL] [Abstract][Full Text] [Related]
19. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.
Snyder JP; Nettles JH; Cornett B; Downing KH; Nogales E
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5312-6. PubMed ID: 11309480
[TBL] [Abstract][Full Text] [Related]
20. EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme.
Ogura H; Nishida CR; Hoch UR; Perera R; Dawson JH; Ortiz de Montellano PR
Biochemistry; 2004 Nov; 43(46):14712-21. PubMed ID: 15544342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]